Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05457569

Acceptability and Feasibility of Implementing a Coordinated Hospital/Non-hospital Parenting Support and Prevention Program for Families of Infants at High Neurodevelopmental Risk After Neonatal Intensive Care Hospitalization

The PRéPaR project aims to construct, with the help of parents and early care providers, a support program for the families of infants at an increased risk for neurodevelopmental disorders, and to evaluate the acceptability and feasibility of such a program. This program aims to strengthen parenting skills, support infant development and improve the continuity of hospital/non-hospital care, including early identification of neurodevelopmental motor disorders and continuation of the support initiated during neonatal hospitalization.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

WP1:

  • For the group of parents of children with documented neurodevelopmental difficulties, their child must meet the following three conditions:
  • Be between 18 months and 48 months corrected age at the time of the first focus group
  • Have at least one risk factor putting them at high neurodevelopmental risk at birth:
  • Preterm infant ≤ 31 WG + 6 days
  • Birth weight less than 1500g
  • Child who has had a stroke or stages 2 or 3 hypoxic-ischaemic encephalopathy of the newborn according to the Sarnat classification
  • Central neurological lesion, diagnosed on brain imaging.
  • Present an abnormal, non-transient clinical state: diagnosis of cerebral palsy made or in progress (GMFCS 1 to 5), central neurological syndrome, diagnosed neurodevelopmental disorder.

The parents must be able to participate in the 3 interviews (T1, T2 and T3).

  • For the group of infants at high neurodevelopmental risk at hospital discharge, their child must meet the following two conditions:
  • Be between 34 weeks of amenorrhea (i.e., 1.5 months premature) and 12 months of corrected age at the time of the first focus group,
  • Have at least one risk factor putting them at high neurodevelopmental risk at birth:
  • Preterm infant ≤ 31 WG + 6 days
  • Birth weight less than 1500g
  • Child who has had a stroke or stages 2 or 3 hypoxic-ischaemic encephalopathy of the newborn according to the Sarnat classification
  • Central neurological lesion, diagnosed on brain imaging.

The parents must be able to participate in the 3 interviews (T1, T2 and T3).

  • Professionals and parent support groups:

Physiotherapists in private practice, labor and delivery nurses of the Maternal and Child Protection, CAMSP (psychomotricians, psychologists) and doctors involved in the care of children at developmental risk in charge of the follow-up of children for whom the parents have agreed to participate in the study. These professionals must in turn have agreed to participate in the study. User representatives (SOS Préma, Le Neurogroup...) who have agreed to participate in the study.

WP2:

  • Parents of children hospitalized in the neonatal services of the CHU Dijon who meet at least one of the following criteria:
  • Be between 34 weeks of amenorrhea (1.5 months premature) and 3 months of corrected age (3 months post-term)
  • Have at least one risk factor putting them at high neurodevelopmental risk at birth:
  • Child who has had a stroke or stages 2 or 3 hypoxic-ischaemic encephalopathy of the newborn according to the Sarnat classification
  • Central neurological lesion, diagnosed on brain imaging.
  • Professionals:

Physiotherapists in private practice, labor and delievery nurses of the Maternal and Child Protection, CAMSP (psychomotricians, psychologists) and physicians involved in the care of children at developmental risk in charge of the follow-up of the children whose parents agreed to participate in the study. These professionals must in turn have agreed to participate in the study.

Exclusion criteria

  • Parents who are physically or cognitively unable to participate in a group interview or who do not have a sufficient command of French.
  • Parents who are minors
  • Parents under legal protection
  • Parents of children with major orthopedic or traumatic disorders unrelated to the high risk of cerebral palsy.

Treatment and study plan

Focus group (FC) - WP1

Other

3 group meetings for each group of parents:

  • Parents only
  • Parents and representatives of patient support groups
  • Parents and health professionals specialized in the care of these children at risk

Child Neurodevelopment Questionnaires - WP2

Other

during the 4th month of corrected infant age

Evaluation of compliance for the acquired skills in terms of development support - WP2

Other

during the 4th month of corrected infant age

Evaluation of physiotherapist satisfaction with the follow-up and the time spent at the consultation - WP2

Other

at the end of the study

4 Focus Group (FC) - WP2

Other
  • Parents who accepted the follow-up
  • Parents who have partially completed the programme
  • Maternal and Child Protection & CAMSP professionals
  • Physiotherapists in a private practice

Primary outcomes

  1. Typology, categorization and operationalization of parental needs and expectations

    Time frame: Through WP1 completion an average of 18 months

    These will be used to develop of the early education program

  2. Typology of perceived subjective representations and description of barriers and levers to use with parents and professionals

    Time frame: through WP2 completion an average of 16 months

Study contacts

Contact information is provided by the study sponsor or research team.

Sandrine JANDET CARON

CONTACT

[email protected]

0672089035

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire Dijon

Other

Registry information

Acronym: PRéPaR

Important dates

Study start
2023
Primary completion
2025
Study completion
2025
First posted
Jul 14, 2022
Registry last updated
Jul 22, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.